- Home
- / Sihuan Pharmaceutical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Sihuan Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.7
2024-10-29
Market Capitalization
$6.6 B
2024-10-29
Revenue
¥2.6 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.9B | 2.9B | 2.5B | 3.3B | 2.4B | 1.9B | 1.9B | 2.6B |
| Cost of goods sold | 233.3M | 243.9M | 287.9M | 710.7M | 753.6M | 485.2M | 574.4M | 753.7M |
| Gross profit | 3.2B | 3.1B | 2.2B | 2.6B | 1.6B | 1.4B | 1.4B | 2.0B |
| Gross profit margin, % | 106.2% | 89.8% | 79.3% | 68.8% | 76.6% | 73.6% | 75.1% | |
| Operating expense total | 1.2B | 1.4B | 1.7B | 1.9B | 2.1B | 1.5B | 1.8B | 1.5B |
| Depreciation and amortization | 305.0M | 4.2B | 265.2M | 432.8M | 1.4B | 79.7M | 85.0M | 62.4M |
| EBITDA | 2.0B | 1.7B | 546.7M | 560.1M | (578.1M) | (176.2M) | (367.6M) | 521.8M |
| EBITDA margin, % | 58.4% | 22.1% | 17.0% | -24.3% | -9.5% | -19.3% | 19.9% | |
| EBIT | 1.7B | (2.5B) | 593.5M | 444.7M | (1.7B) | (164.8M) | (341.6M) | 536.9M |
| EBIT margin, % | -88.0% | 24.0% | 13.5% | -72.0% | -8.9% | -18.0% | 20.5% | |
| Interest income | 164.6M | 169.7M | 135.7M | 163.9M | 146.8M | 147.9M | 175.5M | 98.8M |
| Interest expense | 6.1M | 4.9M | 8.2M | 119.3M | 211.2M | 269.3M | 274.9M | 201.6M |
| Pre tax profit | 2.0B | (2.5B) | 730.9M | 486.0M | (2.1B) | (161.3M) | (428.3M) | 417.2M |
| Income tax expense | 332.8M | 290.4M | 219.0M | 253.3M | 196.9M | 96.4M | 43.3M | 231.8M |
| Net Income | 1.7B | (2.8B) | 511.9M | 232.8M | (2.3B) | (257.7M) | (471.5M) | 185.4M |